Argatroban Anticoagulation for Cardiac Surgery with Cardiopulmonary Bypass in an Infant with Double Outlet Right Ventricle and a History of Heparin-induced Thrombocytopenia
Michael L. Ciccolo MD
Cardiothoracic Surgery, Cardiovascular Surgical Associates,
University of Nevada School of Medicine,
Search for more papers by this authorJonathan Bernstein MD
Pediatric Hematology and Oncology, Childrens Center for Cancer and Blood Disease,
Search for more papers by this authorJuan C. Collazos MD
Children's Heart Center, and
Department of Cardiology and Pediatrics,
Search for more papers by this authorRuben J. Acherman MD
Children's Heart Center, and
Department of Cardiology and Pediatrics,
Search for more papers by this authorHumberto Restrepo MD, MPH
Children's Heart Center, and
Department of Cardiology and Pediatrics,
Search for more papers by this authorJames M. Winters CCP
Clinical Technician Associates, Las Vegas, Nev, USA
Search for more papers by this authorJustin Krueger CCP
Clinical Technician Associates, Las Vegas, Nev, USA
Search for more papers by this authorCorresponding Author
William N. Evans MD
Children's Heart Center, and
Department of Cardiology and Pediatrics,
William N. Evans, MD, Children's Heart Center, 3006 S. Maryland Pkwy., Suite 690, Las Vegas, NV 89109, USA. Tel: (+1) 702-732-1290; Fax: (+1) 702-732-1385; E-mail: [email protected]Search for more papers by this authorMichael L. Ciccolo MD
Cardiothoracic Surgery, Cardiovascular Surgical Associates,
University of Nevada School of Medicine,
Search for more papers by this authorJonathan Bernstein MD
Pediatric Hematology and Oncology, Childrens Center for Cancer and Blood Disease,
Search for more papers by this authorJuan C. Collazos MD
Children's Heart Center, and
Department of Cardiology and Pediatrics,
Search for more papers by this authorRuben J. Acherman MD
Children's Heart Center, and
Department of Cardiology and Pediatrics,
Search for more papers by this authorHumberto Restrepo MD, MPH
Children's Heart Center, and
Department of Cardiology and Pediatrics,
Search for more papers by this authorJames M. Winters CCP
Clinical Technician Associates, Las Vegas, Nev, USA
Search for more papers by this authorJustin Krueger CCP
Clinical Technician Associates, Las Vegas, Nev, USA
Search for more papers by this authorCorresponding Author
William N. Evans MD
Children's Heart Center, and
Department of Cardiology and Pediatrics,
William N. Evans, MD, Children's Heart Center, 3006 S. Maryland Pkwy., Suite 690, Las Vegas, NV 89109, USA. Tel: (+1) 702-732-1290; Fax: (+1) 702-732-1385; E-mail: [email protected]Search for more papers by this authorABSTRACT
Heparin-induced thrombocytopenia (HIT) is a life-threatening complication of heparin therapy. Anticoagulation in pediatric patients with HIT is challenging as there are no approved heparin substitutes. We report the use of the anticoagulant argatroban for cardiac surgery with cardiopulmonary bypass in an infant with double outlet right ventricle and a history of HIT.
References
- 1 Matthai WH. Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia. Curr Hematol Rep. 2006; 5: 95–99.
- 2 Schmugge M, Risch L, Huber AR, Benn A, Fischer J. Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients. Pediatrics. 2002; 109: E10.
- 3 Hursting MJ, Dubb J, Verme-Gibboney CN. Argatroban anticoagulation in pediatric patients. A literature analysis. J Pediatr Hematol Oncol. 2006; 28: 4–10.
- 4 Rish L, Fischer JE, Herklotz R, Huber AR. Heparin induced thrombocytopenia in paediatrics: clinical characteristics, therapy and outcomes. Intensive Care Med. 2004; 30: 1615–1624.
- 5 Potter KE, Raj A, Sullivan JE. Argatroban for anticoagulation in pediatric patients with heparin-induced thrombocytopenia requiring extracorporeal life support. J Pediatr Hematol Oncol. 2007; 29: 265–268.
- 6 Scott LK, Grier LR, Conrad SA. Heparin-induced thrombocytopenia in a pediatric patient receiving extracorporeal membrane oxygenation managed with argatrobandouble dagger. Pediatr Crit Care Med. 2006; 7: 473–475.
- 7 Dyke PC, Russo P, Mureebe L, Russo J, Tobias JD. Argatroban for anticoagulation during cardiopulmonary bypass in an infant. Pediatr Anesthesia. 2005; 15: 328–333.
- 8 Mejak B, Giacomuzzi C, Shen I, Boshkov L, Ungerleider R. Cardiopulmonary bypass using argatroban as an anticoagulant for 6.0 kg pediatric patient. J Extra Corpor Technol. 2005; 37: 303–305.
- 9 Malherbe S, Tsui BCH, Stobart K, Koller J. Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII. Anethesiology. 2004; 100: 443–445.
- 10 Alsoufi B, Boshkow LK, Kirby A, et al. Heparin-induced thrombocytopenia (HIT) in pediatric cardiac surgery: an emerging cause of morbidity and mortality. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2004; 7: 155–171.
- 11 Murphy GS, Marymont JH. Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2007; 21: 113–126.
- 12 Ohteki H, Furukawa K, Ohnishi H, Narita Y, Sakai M, Doi K. Clinical experience of argatroban for anticoagulation in cardiovascular surgery. Jpn J Thorac Cardiovasc Surg. 2000; 48: 39–46.
- 13 Gasparovic H, Nathan NS, Fitzgerald D, Aranki SF. Severe argatroban-induced coagulopathy in a patient with a history of heparin-induced thrombocytopenia. Ann Thorac Surg. 2004; 78: e89–e91.
- 14 Kurup V, Transue S, Wu Y, Rinder HM, Barash P, Dewar M. Cardiac surgery in a patient with heparin-induced thrombocytopenia—caution with the use of the direct thrombin inhibitor, argatroban. Conn Med. 2006; 70: 245–250.
